EUDA Health Holdings Ltd

Análisis de la acción EUDA Health Holdings Ltd (EUDA)

$13.870

-0.889 (-6.41%)Al cierre

Loading chart…
Máximo
16.009
Apertura
15.350
Precio medio ponderado por volumen
14.46
Volumen
28.84K
Capitalización
146.48M
Mínimo
13.510
Importe
417.13K
EV/EBITDA, TTM
0.00

EUDA Health Holdings Limited is a health technology company. The Company operates a southeast Asian digital healthcare ecosystem. Its unified artificial intelligence platform assesses patients' medical history, triages conditions, digitally connects patients with clinicians, and predicts optimal treatment outcomes. Its holistic approach supports patients throughout all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and aftercare services. Its medical urgent care services provide healthcare assistance and medical evacuation to individual and corporate clients. Its property management service covers the management of properties, such as condominiums and shopping malls. Its services include e-triage, GP consult, e-medical certificates, and medical prescriptions. Its EUDA platform provides medical services from primary to post-surgery care and ongoing preventive healthcare for clients, regardless of the level of healthcare required.

Análisis de IA of EUDA Health Holdings Ltd (EUDA)

Comprar

EUDA Health Holdings appears to be a good buy right now due to its recent recovery in Nasdaq compliance, which can enhance investor confidence. The stock is currently priced at $15.57, significantly lower than its 52-week high of $71.20, indicating potential for upside. Additionally, the stock has shown a 5-day change of +7.68%, suggesting a positive short-term trend. However, the main risk is its YTD change of -68.35%, indicating significant volatility and the need for careful monitoring.

Métricas de valoración

El PER previsto actual de EUDA Health Holdings Ltd (EUDA) es 7.81, frente a su media de 5 años de -6.75.

PER previsto

Valor razonable
Media 5A P/E
-6.75
P/E actual
7.81
Sobrevalorada
21.27
Infravalorada
-34.77

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
-4.08
EV/EBITDA actual
0.00
Sobrevalorada
1.31
Infravalorada
-9.47

Precio/ventas previsto

Infravalorado
Media 5A P/S
6.69
P/S actual
0.00
Sobrevalorada
12.36
Infravalorada
1.03

Cronología de eventos

2026-07-30 (ET)

08:00:00

EUDA Health Signs MOU with GO POSB to Advance Cell Therapy

2026-07-28 (ET)

06:30:00

EUDA Health Signs Tripartite MOU with GO POSB for Next-Gen Therapies

2026-07-14 (ET)

10:30:00

EUDA Health Holdings Ltd Trading Halted Due to Volatility

2026-05-06 (ET)

09:40:00

EUDA Health Holdings Ltd Trading Halted Due to Volatility Trading Pause

2026-04-29 (ET)

10:00:00

EUDA Health Holdings Ltd Trading Halted Due to Volatility

Noticias

Preguntas frecuentes sobre EUDA, respondidas por Alphio AI

EUDA Health Holdings Limited is a health technology company. The Company operates a southeast Asian digital healthcare ecosystem. Its unified artificial intelligence platform assesses patients' medical history, triages conditions, digitally connects patients with clinicians, and predicts optimal treatment outcomes. Its holistic approach supports patients throughout all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and aftercare services. Its medical urgent care services provide healthcare assistance and medical evacuation to individual and corporate clients. Its property management service covers the management of properties, such as condominiums and shopping malls. Its services include e-triage, GP consult, e-medical certificates, and medical prescriptions. Its EUDA platform provides medical services from primary to post-surgery care and ongoing preventive healthcare for clients, regardless of the level of healthcare required. It operates in the Industrials sector (SERVICES-HEALTH SERVICES industry).

EUDA Health Holdings appears to be a good buy right now due to its recent recovery in Nasdaq compliance, which can enhance investor confidence. The stock is currently priced at $15.57, significantly lower than its 52-week high of $71.20, indicating potential for upside. Additionally, the stock has shown a 5-day change of +7.68%, suggesting a positive short-term trend. However, the main risk is its YTD change of -68.35%, indicating significant volatility and the need for careful monitoring.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Artículos relacionados

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar